Recce Pharmaceuticals Ltd. (AU:RCE) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Recce Pharmaceuticals Ltd. (ASX: RCE) has requested a trading halt on its securities as it prepares to make a significant announcement regarding its Phase 3 Diabetic Foot Ulcer Infection Approval. The halt will remain until December 9, 2024, or until the announcement is released, creating anticipation among investors about the company’s future prospects.
For further insights into AU:RCE stock, check out TipRanks’ Stock Analysis page.
